TOKYO, Nov 20, 2024 - (JCN Newswire) - - Eisai Co., Ltd. announced today that the amyotrophic lateral sclerosis (ALS) treatment "Rozebalamin for Injection25 mg" (mecobalamin) has been launched in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback